# Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity

Study · id `cardio:ct-nct01493999` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01493999](<https://clinicaltrials.gov/study/NCT01493999>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01493999

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 147 participants.

## Technical summary

Registry record NCT01493999. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 147 participants (enrolled count; ClinicalTrials.gov record NCT01493999, source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01493999, source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)
- Primary completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01493999, source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)
- Completion: 2013-04 (actual) (ClinicalTrials.gov record NCT01493999, source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)
- Countries: Hungary (ClinicalTrials.gov record NCT01493999, source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01493999-2014-10-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
- Acronym: TREAT-HPR
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Clopidogrel reloading
- Intervention (Drug): Prasugrel
- Lead sponsor: University of Pecs
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)

## Provenance

Content hash: b04fd5056a9a6f4dbacdc3a507bb3424413db35b43dbe47d1635a43e338929fe
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
